US Stem Cell Inc (USRM)

[Dragon Lady]

NO. "And still HIGHER HIGHS AND HIGHER LOWS than this point last year"

Actually, at early Jan of last yr, it was at ONE CENT which is exactly where it's at today. It's gone nowhere. DEAD MONEY, during one of the greatest bull markets in world history.

The stock has been making LOWER HIGHS and LOWER LOWS for 9 plus months now, a sustained, unbroken downtrend. A major downtrend and technical weakness of every form.

And that's despite a doubling of the O/S shares via massive dilution and while increasing the A/S to 2 BILLION in preparation to dilute continuously, non-stop, for forever essentially, for as long as they can keep the gig going. Dilution is all they got.

From latest 10-Q filing, Q-3, 2014, PAGE 9:

" Fully diluted shares outstanding were 659,543,477 and 323,296,916 for the three months ended September 30, 2014 and 2013, "

That is a staggering amount of share crushing dilution with nothing to show for it but a ONE CENT share price, a massively collapsed market cap now parked at about $5.x to maybe $6 million and massive debts and short term obligations due with little to no cash and 4 or 5 yr old trials that have gone nowhere, never budged a single step forward, just stagnating, going nowhere.



A picture is worth a 1000 words. The reality of it. Staggering losses. Dilution, endless dilution has consequences, as does continuous reliance on toxic, convertible debt financing, most of which goes to pay the ever increasing base salaries and now very large cash bonuses to just 2 people in the "company".

From last 10-Q, PAGE 23:

"Employment agreements
On July 28, 2014, the Company’s Board of Directors approved the 2014/2015 salary for Mike Tomas, Chief Executive Officer, at $525,000 per year, beginning July 1, 2014 with an incentive bonus ranging from $150,000 to $500,000. In addition, the Board of Directors will grant Mr. Tomas options to be determined on or before June 30, 2015. The Company’s Board of Directors approved a bonus of $500,000 and options to acquire 10,000,000 shares of the Company’s common stock for ten years with four year vesting and a cashless exercise provision at an exercise price equal to the five day average closing price of the Company’s common stock as of August 1, 2014. The cash bonus may be paid in the form of a six month promissory note.

On July 28, 2014, the Company’s Board of Directors approved the 2014/2015 salary for Kristin Comella, Chief Scientific Officer, at $250,000 per year, beginning July 1, 2014 with an incentive bonus ranging from $100,000 to $300,000. In addition, the Board of Directors will grant Ms. Comella options to be determined on or before June 30, 2015. The Company’s Board of Directors approved a bonus of $300,000 and options to acquire 5,000,000 shares of the Company’s common stock for ten years with four year vesting and a cashless exercise provision at an exercise price equal to the five day average closing price of the Company’s common stock as of August 1, 2014. The cash bonus may be paid in the form of a six month promissory note."

That is $525K + $500K + $250K + $300K = $1,575,000 dollars per yr to just 2 people, in a company of 4 full time and 1 part time (see SEC filing)- $1.575 MILLION dollars a yr to 2 people, in a company that just finished their last qtr with $46K, $46 thousand, lousy cash total to their name (See SEC filing, most recent 10-Q, cash on hand entry).

Notice the bonuses were of course the top of the stated range- the very maximum amount. The 2 receiving the bonuses make up 2 out of the 6 BOD members, 1/3, so they're self voting their own pay increase to a large degree.

The company is so cash poor, they often pay ordinary bills in shares of common stock, yet issue out enormous bonuses to just 2 people. And even the bonuses can't be paid immediately as the company is so cash poor- so they issue themselves "promissory notes" until they can dilute some more to pay themselves.

OTC-ville to the tee IMO. Classic.